KYMAB GROUP LIMITED

Company number 10414057 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Overview

Company type
Private Limited Company
Incorporated
2016-10-06
Registered office
The Eddeva Building (B920), Babraham Research Campus, Cambridge, England, CB22 3AT
Postcode
CB22 3AT
Capital
0 GBP
Accounts category
Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-09-23
Next due by
2026-10-07
View filing history →

Nature of business (SIC)

  • 82990 Other business support service activities not elsewhere classified

Officers 5 current · 9 resigned

Appointed 2026-03-25
Appointed 2021-08-01
COMPANY DIRECTOR AND CONSULTANT Appointed 2016-10-06
ALLAN BRADLEY Director
SCIENTIST AND INSTITUTE DIRECTOR Appointed 2016-10-06
ANNE HYLAND Secretary
Appointed 2016-10-06

View all officers and resignations →

Group structure 1 subsidiary

Controlled by Sanofi (FR0000120578) — since 2021-04-08

Controlled by THE WELLCOME TRUST LIMITED — since 2016-11-23

From persons-with-significant-control filings on the public register.

Contact details

Website
kymab.com

At this address

39

companies are registered at this postcode →

The class of 2016

19%

of the 49,286 companies in this sector incorporated in 2016 are still active today; 77% have since been dissolved.

A fact about the year, not a forecast for this company.